Interleukin 1-beta (IL-1β) enhances contractile responses in endothelium-denuded aorta from hypertensive, but not normotensive, rats

Vascular Pharmacology

Volumn 47, Issue 2-3, 2007, Pages 160-165

  Dorrance, Anne M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Hypertension; Inflammation; Vasoconstriction

Indexed keywords

INDOMETACIN; INTERLEUKIN 1BETA; PHENYLEPHRINE; PROSTAGLANDIN SYNTHASE; PROTEIN TYROSINE KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; AORTA CONSTRICTION; AORTA MEDIA; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM LESION; INCUBATION TIME; MALE; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM; VASCULAR RING; VASCULAR SMOOTH MUSCLE; WISTAR KYOTO RAT;

ANIMALS; AORTA, THORACIC; DISEASE MODELS, ANIMAL; HYPERTENSION; INDOMETHACIN; INTERLEUKIN-1BETA; ISOMETRIC CONTRACTION; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOGRAPHY; PHENYLEPHRINE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRIMIDINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SRC-FAMILY KINASES; VASOCONSTRICTOR AGENTS;

EID: 34447621374     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2007.05.007     Document Type: Article

References (25)

1. + channels as a new mechanism of agonist-induced vasoconstriction. Proc. Natl. Acad. Sci. U. S. A. 99 22 (2002) 14560-14565
2. Banes A., Florian J.A., and Watts S.W. Mechanisms of 5-hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle. J. Pharmacol. Exp. Ther. 291 3 (1999) 1179-1187
3. Bartlett S.R., Sawdy R., and Mann G.E. Induction of cyclooxygenase-2 expression in human myometrial smooth muscle cells by interleukin-1beta: involvement of p38 mitogen-activated protein kinase. J. Physiol. 520 Pt 2 (1999) 399-406
4. Bautista L.E. Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence. J. Hum. Hypertens. 17 4 (2003) 223-230
5. Chang Y.J., Wu M.S., Lin J.T., Sheu B.S., Muta T., Inoue H., and Chen C.C. Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-kappaB activation. Mol. Pharmacol. 66 6 (2004) 1465-1477
6. Dalekos G.N., Elisaf M., Bairaktari E., Tsolas O., and Siamopoulos K.C. Increased serum levels of interleukin-1beta in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients?. J. Lab. Clin. Med. 129 3 (1997) 300-308
7. De Salvatore G., De Salvia M.A., Piepoli A.L., Natale L., Porro C., Nacci C., Mitolo C.I., and Mitolo-Chieppa D. Effects of in vivo treatment with interleukins 1beta and 6 on rat mesenteric vascular bed reactivity. Auton. Autacoid. Pharmacol. 23 2 (2003) 125-131
8. Dinarello C.A. The IL-1 family and inflammatory diseases. Clin. Exp. Rheumatol. 20 5 Suppl 27 (2002) S1-S13
9. Gui Y., Zheng X.L., and Hollenberg M.D. Interleukin-1beta, Src- and non-Src tyrosine kinases, and nitric oxide synthase induction in rat aorta in vitro. Am. J. Physiol. Heart Circ. Physiol. 279 2 (2000) H566-H576
10. Hermann M., Camici G., Fratton A., Hurlimann D., Tanner F.C., Hellermann J.P., Fiedler M., Thiery J., Neidhart M., Gay R.E., Gay S., Luscher T.F., and Ruschitzka F. Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension. Circulation 108 19 (2003) 2308-2311
11. Morishige K., Shimokawa H., Eto Y., Kandabashi T., Miyata K., Matsumoto Y., Hoshijima M., Kaibuchi K., and Takeshita A. Adenovirus-mediated transfer of dominant-negative rho-kinase induces a regression of coronary arteriosclerosis in pigs in vivo. Arterioscler. Thromb. Vasc. Biol. 21 4 (2001) 548-554
12. Park Y.G., Kang S.K., Kim W.J., Lee Y.C., and Kim C.H. Effects of TGF-beta, TNF-alpha, IL-beta and IL-6 alone or in combination, and tyrosine kinase inhibitor on cyclooxygenase expression, prostaglandin E2 production and bone resorption in mouse calvarial bone cells. Int. J. Biochem. Cell Biol. 36 11 (2004) 2270-2280
13. Peeters A.C., Netea M.G., Janssen M.C., Kullberg B.J., Van der Meer J.W., and Thien T. Pro-inflammatory cytokines in patients with essential hypertension. Eur. J. Clin. Investig. 31 1 (2001) 31-36
14. Rikitake Y., Hirata K., Kawashima S., Takeuchi S., Shimokawa Y., Kojima Y., Inoue N., and Yokoyama M. Signaling mechanism underlying COX-2 induction by lysophosphatidylcholine. Biochem. Biophys. Res. Commun. 281 5 (2001) 1291-1297
15. Sanz-Rosa D., Oubina M.P., Cediel E., de Las Heras N., Vegazo O., Jimenez J., Lahera V., and Cachofeiro V. Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-kappaB/IkappaB system. Am. J. Physiol. Heart Circ. Physiol. 288 1 (2005) H111-H115
16. Shi W., Meininger C.J., Haynes T.E., Hatakeyama K., and Wu G. Regulation of tetrahydrobiopterin synthesis and bioavailability in endothelial cells. Cell Biochem. Biophys. 41 3 (2004) 415-434
17. Sironi L., Gelosa P., Guerrini U., Banfi C., Crippa V., Brioschi M., Gianazza E., Nobili E., Gianella A., de Gasparo M., and Tremoli E. Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall. J. Pharmacol. Exp. Ther. 311 3 (2004) 989-995
18. Soler M., Camacho M., and Vila L. Imidazolineoxyl N-oxide prevents the impairment of vascular contraction caused by interleukin-1beta through several mechanisms. J. Infect. Dis. 188 6 (2003) 927-937
19. Touyz R.M., He G., Wu X.H., Park J.B., Mabrouk M.E., and Schiffrin E.L. Src is an important mediator of extracellular signal-regulated kinase 1/2-dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients. Hypertension 38 1 (2001) 56-64
20. Touyz R.M., Wu X.H., He G., Park J.B., Chen X., Vacher J., Rajapurohitam V., and Schiffrin E.L. Role of c-Src in the regulation of vascular contraction and Ca2+ signaling by angiotensin II in human vascular smooth muscle cells. J. Hypertens. 19 3 (2001) 441-449
21. Touyz R.M., Wu X.H., He G., Salomon S., and Schiffrin E.L. Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension 39 2 Pt 2 (2002) 479-485
22. Vicaut E., Rasetti C., and Baudry N. Effects of tumor necrosis factor and interleukin-1 on the constriction induced by angiotensin II in rat aorta. J. Appl. Physiol. 80 6 (1996) 1891-1897
23. White L.R., Juul R., Skaanes K.O., and Aasly J. Cytokine enhancement of endothelin ET(B) receptor-mediated contraction in human temporal artery. Eur. J. Pharmacol. 406 1 (2000) 117-122
24. Wu R., Laplante M.A., and de Champlain J. Cyclooxygenase-2 inhibitors attenuate angiotensin II-induced oxidative stress, hypertension, and cardiac hypertrophy in rats. Hypertension 45 6 (2005) 1139-1144
25. Yang N.C., Lu L.H., Kao Y.H., and Chau L.Y. Heme oxygenase-1 attenuates interleukin-1beta-induced nitric oxide synthase expression in vascular smooth muscle cells. J. Biomed. Sci. 11 6 (2004) 799-809